12.54
price up icon8.01%   0.93
 
loading
Schlusskurs vom Vortag:
$11.61
Offen:
$11.61
24-Stunden-Volumen:
1.65M
Relative Volume:
2.38
Marktkapitalisierung:
$571.12M
Einnahmen:
$159.01M
Nettoeinkommen (Verlust:
$-21.72M
KGV:
-24.12
EPS:
-0.52
Netto-Cashflow:
$-20.63M
1W Leistung:
+7.46%
1M Leistung:
+28.88%
6M Leistung:
-33.62%
1J Leistung:
+35.71%
1-Tages-Spanne:
Value
$11.61
$12.75
1-Wochen-Bereich:
Value
$11.25
$12.75
52-Wochen-Spanne:
Value
$7.34
$21.00

Axogen Inc Stock (AXGN) Company Profile

Name
Firmenname
Axogen Inc
Name
Telefon
(386) 462-6817
Name
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Name
Mitarbeiter
452
Name
Twitter
@AxoGen
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
AXGN's Discussions on Twitter

Vergleichen Sie AXGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
AXGN
Axogen Inc
12.54 531.50M 159.01M -21.72M -20.63M -0.52
Medical Devices icon
ABT
Abbott Laboratories
125.73 228.77B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
103.16 153.09B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
395.15 149.27B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.65 114.31B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.30 45.06B 5.54B 4.18B 623.10M 7.00

Axogen Inc Stock (AXGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-17 Eingeleitet Lake Street Buy
2024-07-01 Eingeleitet Raymond James Outperform
2022-11-11 Fortgesetzt Jefferies Buy
2022-05-09 Hochstufung Canaccord Genuity Hold → Buy
2022-03-11 Fortgesetzt Cantor Fitzgerald Overweight
2020-10-23 Eingeleitet Guggenheim Buy
2020-06-16 Fortgesetzt Cantor Fitzgerald Overweight
2020-05-07 Herabstufung Canaccord Genuity Buy → Hold
2020-04-02 Herabstufung BTIG Research Buy → Neutral
2019-08-07 Herabstufung William Blair Outperform → Mkt Perform
2019-07-12 Eingeleitet Canaccord Genuity Buy
2018-03-02 Bestätigt Lake Street Buy
2018-01-05 Fortgesetzt Cantor Fitzgerald Overweight
2017-11-30 Eingeleitet Jefferies Buy
2017-11-21 Bestätigt Lake Street Buy
2017-07-31 Eingeleitet Leerink Partners Outperform
2017-06-30 Eingeleitet Cantor Fitzgerald Overweight
2017-03-06 Eingeleitet ROTH Capital Buy
2016-11-22 Hochstufung Lake Street Hold → Buy
2016-11-07 Bestätigt Wedbush Outperform
2016-11-03 Herabstufung Lake Street Buy → Hold
2016-08-04 Bestätigt Wedbush Outperform
2014-05-14 Eingeleitet Dawson James Buy
2013-10-31 Bestätigt Ladenburg Thalmann Buy
Alle ansehen

Axogen Inc Aktie (AXGN) Neueste Nachrichten

pulisher
06:34 AM

Axogen, Inc.'s (NASDAQ:AXGN) Shares Leap 29% Yet They're Still Not Telling The Full Story - simplywall.st

06:34 AM
pulisher
05:37 AM

Arizona State Retirement System Makes New $222,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

05:37 AM
pulisher
04:48 AM

Axogen Inc. Stock Analysis and ForecastHigh-profit trading signals - Autocar Professional

04:48 AM
pulisher
Jul 22, 2025

Is Axogen Inc. a good long term investmentExtraordinary profit generation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Axogen, Inc. to Announce 2025 Second Quarter Financial Results on August 5, 2025 - Quiver Quantitative

Jul 22, 2025
pulisher
Jul 22, 2025

Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Axogen Inc. stockAccelerated investment success - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Axogen Inc. stock attracts strong analyst attentionFree AI-Powered Stock Predictions - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Axogen Inc. stock pricePhenomenal investment performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Leerink Partnrs Brokers Lower Earnings Estimates for AxoGen - Defense World

Jul 18, 2025
pulisher
Jul 17, 2025

Leerink Partnrs Has Pessimistic View of AxoGen Q4 Earnings - Defense World

Jul 17, 2025
pulisher
Jul 15, 2025

why axogen inc. stock attracts strong analyst attentionRisk Aware High Growth Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Axogen Inc. stock performs during market volatilityFree Premium Stock Market Reports - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Axogen Inc. stock price move sharplyInvestor Favorite Picks - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

How To Trade (AXGN) - news.stocktradersdaily.com

Jul 14, 2025
pulisher
Jul 11, 2025

Axogen (NASDAQ:AXGN) swells 10% this week, taking three-year gains to 46% - simplywall.st

Jul 11, 2025
pulisher
Jul 07, 2025

AxoGen’s SWOT analysis: nerve repair leader’s stock poised for growth - Investing.com Australia

Jul 07, 2025
pulisher
Jul 06, 2025

AxoGen’s SWOT analysis: nerve repair leader’s stock poised for growth By Investing.com - Investing.com Canada

Jul 06, 2025
pulisher
Jul 03, 2025

Learn to Evaluate (AXGN) using the Charts - news.stocktradersdaily.com

Jul 03, 2025
pulisher
Jul 02, 2025

Axogen Showcases Nerve Repair Vision at Goldman Sachs - Yahoo Finance

Jul 02, 2025
pulisher
Jun 27, 2025

Axogen, Inc. (NASDAQ:AXGN) Is Expected To Breakeven In The Near Future - 富途牛牛

Jun 27, 2025
pulisher
Jun 26, 2025

15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey

Jun 26, 2025
pulisher
Jun 23, 2025

Long Term Trading Analysis for (AXGN) - news.stocktradersdaily.com

Jun 23, 2025
pulisher
Jun 21, 2025

SG Americas Securities LLC Has $704,000 Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

Jun 21, 2025
pulisher
Jun 20, 2025

AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by Rhumbline Advisers - Defense World

Jun 20, 2025
pulisher
Jun 14, 2025

Institutional investors in Axogen, Inc. (NASDAQ:AXGN) see US$53m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st

Jun 14, 2025
pulisher
Jun 13, 2025

Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail

Jun 13, 2025
pulisher
Jun 11, 2025

AxoGen at Goldman Sachs Conference: Strategic Path to Nerve Repair Growth - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Transcript : Axogen, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener

Jun 11, 2025
pulisher
Jun 09, 2025

Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results - The Globe and Mail

Jun 09, 2025
pulisher
Jun 06, 2025

AxoGen, Inc. (NASDAQ:AXGN) Sees Significant Increase in Short Interest - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

AxoGen FY2025 EPS Estimate Decreased by Cantor Fitzgerald - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Axogen Inc (AXGN) Trading Down 3.17% on Jun 4 - GuruFocus

Jun 04, 2025

Finanzdaten der Axogen Inc-Aktie (AXGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$285.57
price up icon 1.64%
medical_devices STE
$223.69
price up icon 0.47%
medical_devices PHG
$25.02
price up icon 1.96%
$85.12
price up icon 1.30%
$76.49
price up icon 3.14%
medical_devices EW
$76.30
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):